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Dear Editor:
I read with great interest the case report by Sun et al. 
(1), entitled "Papillary thyroid carcinoma treated with 
radiofrequency ablation in a patient with hypertrophic 
cardiomyopathy: a case report," which was published in the 
Korean Journal of Radiology (KJR), July 2016. The authors 
presented a subcentimetic papillary thyroid carcinoma 
treated by radiofrequency ablation in an inoperable 
condition.
In the case report, a 52-year-old woman had 9 mm 
sized papillary carcinoma in the right thyroid gland, which 
showed an intrathyroidal location with no lymph node 
enlargement on ultrasound. She was not a candidate for 
thyroid surgery owing to an underlying medical condition, 
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so the authors chose radiofrequency ablation to treat 
thyroid cancer.
However, it is my opinion that simple observation 
for papillary microcarcinoma is more appropriate for 
management of thyroid cancer in such cases. Papillary 
microcarcinoma (measuring 10 mm or less) in the absence 
of other poor prognostic features such as extrathyroidal 
extension or lymph node metastasis runs an indolent 
course, so it is a good candidate for observation (2, 3). Ito 
et al. (4) demonstrated a similar recurrence and mortality 
rate when these cancers were observed rather than treated 
with immediate surgery. Moreover, ablating only the primary 
thyroid carcinoma is not recommended because of a high 
incidence of multiplicity and lymph node metastasis even 
though the carcinoma is small in size (4). Recent American 
Thyroid Association guidelines do not recommend fine 
needle aspiration in subcentimetric thyroid nodules even 
with highly suspicious ultrasound patterns (2), and this 
trend is closely related to a “less is more” paradigm shift in 
the management of thyroid nodules (5).
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